Send the following on WhatsApp
Continue to Chat藥明巨諾宣佈倍諾達®針對兒童及年輕成人復發或難治性B細胞急性淋巴細胞白血病的臨床試驗申請獲批 https://geneonline.news/jwtx-car-t-nmpa-approval/?variant=zh-cn
藥明巨諾宣佈倍諾達®針對兒童及年輕成人復發或難治性B細胞急性淋巴細胞白血病的臨床試驗申請獲批 https://geneonline.news/jwtx-car-t-nmpa-approval/?variant=zh-cn